About Intellectual Property IP Training Respect for IP IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships AI Tools & Services The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars IP Enforcement WIPO ALERT Raising Awareness World IP Day WIPO Magazine Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Webcast WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO Translate Speech-to-Text Classification Assistant Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight
Arabic English Spanish French Russian Chinese
Laws Treaties Judgments Browse By Jurisdiction

Regulation No. 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive No. 2001/20/EC, European Union (EU)

Back

Latest Version in WIPO Lex
Year of Version 2014 Dates Adopted: April 16, 2014 Type of Text IP-related Laws Subject Matter Other Notes The notification by the European Union to the WTO under Article 63.2 of TRIPS states:
'Regulation No. 536/2014 regulates clinical trials in regards to authorization requirements and procedure, implementation as well as the creation of an electronic database for safety reporting.
The Regulation further deals with the manufacture and import of investigational medicinal products and auxiliary medicinal products and their labelling.'

Article 99 under Chapter XIX of the Regulation states that it shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
The Regulation was published on May 24, 2014, and, accordingly, entered into force on June 16, 2014.


Available Texts Main text(s) Main text(s) German Verordnung (EU) Nr. 536/2014 des Europäischen Parlaments und des Rates vom 16. April 2014 über klinische Prüfungen mit Humanarzneimitteln und zur Aufhebung der Richtlinie Nr. 2001/20/EG PDF HTML French Règlement n° 536/2014 du 16 avril 2014 relatif aux essais cliniques de médicaments à usage humain et abrogeant la Directive n° 2001/20/CE PDF HTML English Regulation No. 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive No. 2001/20/EC PDF HTML Portuguese Regulamento (UE) n.° 536/2014 do Parlamento Europeu e do Conselho, de 16 de abril de 2014 , relativo aos ensaios clínicos de medicamentos para uso humano e que revoga a Diretiva n.° 2001/20/CE PDF HTML Italian Regolamento (UE) n. 536/2014 del Parlamento europeo e del Consiglio, del 16 aprile 2014 , sulla sperimentazione clinica di medicinali per uso umano e che abroga la Direttiva n. 2001/20/CE PDF HTML Spanish Reglamento N° 536/2014 de 16 de abril de 2014 sobre los ensayos clínicos de medicamentos de uso humano, y por el que se deroga la Directiva N° 2001/20/CE PDF HTML
Legislation Implements (1 text(s)) Implements (1 text(s))
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (EU173)
Relates to (1 text(s)) Relates to (1 text(s))
Directive 2001/18/EC of the European Parliament & of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms & repealing Council Directive 90/220/EEC (EU161)

WTO Document Reference
IP/N/1/EU/18-IP/N/1/EU/U/5

WIPO Lex No. EU222